Equivalent to the observation in colorectal cancers, most cases with p53 mutations belong to the group that lack methylation, suggesting that p53 mutation and methylation can be two distinct mechanisms that deactivate tumor-suppressor genes in breast cancer. This evidence concerns the gene TP53 and breast carcinoma.